Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Tormey

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Cancer|January 15, 1990
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trialD C Tormey, R Gray, K Gilchrist, et al.
Cancer|October 1, 1982
Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group TrialD C Tormey, R Gelman, P R Band, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of deathF J Cummings, R Gray, D C Tormey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1975
Usefulness of gallium scintigraphy in primary and metastatic breast carcinomaS D Richman, J N Ingle, S M Leveson, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II trial of carboplatin in soft-tissue sarcomaD Goldstein, B Cheuvart, D L Trump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trialD C Tormey, R Gray, M D Abeloff, et al.
Cancer Treatment Reports|July 1, 1983
Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusionR H Earhart, J M Koeller, T E Davis, et al.
Cancer|November 1, 1987
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimideJ Horton, M Knuiman, A M Keller, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.
The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Cancer|January 15, 1990
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trialD C Tormey, R Gray, K Gilchrist, et al.
Cancer|October 1, 1982
Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group TrialD C Tormey, R Gelman, P R Band, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of deathF J Cummings, R Gray, D C Tormey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1975
Usefulness of gallium scintigraphy in primary and metastatic breast carcinomaS D Richman, J N Ingle, S M Leveson, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II trial of carboplatin in soft-tissue sarcomaD Goldstein, B Cheuvart, D L Trump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trialD C Tormey, R Gray, M D Abeloff, et al.
Cancer Treatment Reports|July 1, 1983
Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusionR H Earhart, J M Koeller, T E Davis, et al.
Cancer|November 1, 1987
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimideJ Horton, M Knuiman, A M Keller, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.
The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Pageof 14